Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in immuno research, from the discovery & development of cell & antibody therapies through to omics-based approaches and clinical case studies

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Therapeutic Modalities

Cancer Vaccines: Analysing the Resurgence

Looking at the past, present, and future of cancer vaccines. What are the reasons for past failings? And what's the next step for their development?
Read More
Biomarkers in Immuno-Oncology

A ‘New Age’ of Biomarker Technology? Understanding Identification & Validation of IO Biomarkers

Developing and validating IO biomarkers present challenges, such as working with challenging sample types, interpreting sequencing data, and integrating new technologies into the clinic.
Read More
Autoimmunity & Immunology

Antibody Therapies to Get Boost from Genmab and Argenx Partnership for Immunology and Oncology

The partnership aims to address unmet patient needs in the areas of immunology and cancer.
Read More
Autoimmunity & Immunology

AI Used to Detect Rare Autoimmune Eye Disease

The AI model, called VGG16, analysed CT scans of the eyes of patients and achieved an accuracy of 94.27%.
Read More
Therapeutic Modalities

App Note: CAR-T: A Promising Cell Therapy for Cancer Treatment

This application note by Sino Biological explores the key steps involved in CAR-T production to provide insights into the challenges that may impede successful CAR-T therapy.
Read More
Therapeutic Modalities

NK Cell Therapies and Their Promising Possibilities

Considering the potential of natural killer (NK) cells as immunotherapies for cancer treatment and the various methods being utilised to overcome cancer cells' resistance to NK cells.
Read More
Therapeutic Modalities

Axion Biosystems: In vitro Potency Assays for Immune Cell-Mediated Killing with the Maestro Z

Immunotherapy harnesses the power of the innate and adaptive immune system in various ways to seek out and attack cancer.
Read More
Therapeutic Modalities

Axion Biosystems: Quantifying NK-mediated Cytolysis of Glioblastoma in vitro with Maestro Z

Immunotherapy aims to harness and enhance the body’s immune system to fight cancer.
Read More
Biomarkers in Immuno-Oncology

Axion Biosystems: Organoid Analysis Module

Robust organoid quantification and monitoring.
Read More
Therapeutic Modalities

GD2 CAR-T cells engineered using retroviral transduction or CRISPR editing exhibit strong cytolytic potency against glioma stem cells

Axion BioSystems’ Maestro Z platform offers impedance-based cell analysis for real-time, label-free monitoring of cell viability, morphology, cytolysis, and signaling.
Read More
Therapeutic Modalities

Axion Biosystems: Antibody-dependent Cellular Cytotoxicity of Natural Killer Cells

Trastuzumab promotes natural killer cell activation through antibody-dependent cellular cytotoxicity (ADCC).
Read More
Therapeutic Modalities

Axion Biosystems: CAR T Cell Potency Assessment with 3D Cancer Spheroid Models

The solid tumor microenvironment poses a significant challenge to immune therapies like CART cells.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things immuno